3/19/2013 12:03 PM
When Monsanto lost their patent on Round Up and generics were about to hit the scene, Monsanto released several lower priced generics of their own and thus retained market share.
Why is it that the Syngentas, Bayers and Basfs of the world don't either release a lower priced generic, or even better just drop the price of the name brands to the equivalent of a generic. They have had the benefit, while covered by patents to recoup their research and development costs, so to me the smart move would be to match the generics and continue generating sales to develop new chemistry.
Many of us are in a catch 22 as we know that the generics are cheaper, but by the same token we need to support the developers in order to see new products brought to the market
It may be that this is happening Stateside...I don't know but I do know when it comes to pharmaceuticals I am always hearing advertizing up here saying that Viagara now costs the same as the generic version so why not stick with what you know gets you up. Similar advertizing and marketing is also happening with other off patents drugs.
Am I missing something? or should I go into marketing?